Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
- Registration Number
- NCT00672074
- Lead Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Brief Summary
The purpose of this study is to determine if ipamorelin is safe and effective in the management of post-operative ileus.
- Detailed Description
The safety and efficacy of ipamorelin in the management of post-operative ileus
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 117
- willing to comply with protocol
- undergoing bowel resection surgery
- ASA Class I-III
- Females must not be pregnant
- Body weight 40-150 kg
- mentally incompetent or unable to provide informed consent
- clinically unstable
- significant liver disease
- clinically significant lab or EKG abnormalities
- alcohol or illicit drug abuse
- history of or current surgery that would prevent proper evaluation of safety or efficacy of drug
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 Placebo placebo - 1 Ipamorelin Ipamorelin -
- Primary Outcome Measures
Name Time Method Recovery of GI function Until hospital discharge
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (19)
USC/Norris Cancer Center
🇺🇸Los Angeles, California, United States
Cedars Sinai Medical Center
🇺🇸Los Angeles, California, United States
Palo Alto Veterans Hospital
🇺🇸Palo Alto, California, United States
University of Colorado Hospital
🇺🇸Aurora, Colorado, United States
Denver VA Hospital
🇺🇸Denver, Colorado, United States
Washington Hospital Center
🇺🇸Washington, District of Columbia, United States
Cleveland Clinic of Weston
🇺🇸Weston, Florida, United States
St. Joseph's Hospital of Atlanta
🇺🇸Atlanta, Georgia, United States
University of Illinois at Chicago
🇺🇸Chicago, Illinois, United States
Indiana University Medical Center
🇺🇸Indianapolis, Indiana, United States
Scroll for more (9 remaining)USC/Norris Cancer Center🇺🇸Los Angeles, California, United States